Early Intensive Hand Rehabilitation After Spinal Cord Injury (SCIPAHandsOn)

April 28, 2021 updated by: Mary Galea, University of Melbourne

SCIPA (Spinal Cord Injury and Physical Activity) Hands-On: Early Intensive Hand Rehabilitation After Spinal Cord Injury

Loss of hand function is one of the most devastating consequences of tetraplegia because of the severe impact on activities of daily living (ADL) and the resultant dependency on others. This multi-centre study in 78 participants will measure whether additional hand therapy provided via an electrical stimulator glove and specialised computer workstation improves hand function in people with tetraplegia.

Study Overview

Status

Completed

Conditions

Detailed Description

The study is a multi-centre, assessor-blind, randomised controlled phase III trial in patients with tetraplegia (a spinal cord injury). A total of 78 participants will be randomised into two groups; 1. the experimental group and 2. the control group. The control group will receive their standard rehabilitation care, while the experimental group will receive the standard rehabilitation care plus the study treatment. The study treatment will consist of one hour of extra hand training, 5 times a week, using a specialised glove which provides electrical impulses to the patient's hand allowing them to open and close their hand. The glove will be used to play games on a specialised computer workstation which focuses on hand movement and function.

The main objective of this study is to determine if the experimental treatment is more effective than standard rehabilitation care alone in participants with tetraplegia.

Total study duration is 3 years, including an 18 month recruitment period, an 8-week treatment period followed by 6 month and 12 month follow up assessments.

The progress of the participant's therapy during the study will be assessed by a blinded assessor (the assessor will not know which group the participants are in) using standard physiotherapy and occupational therapy assessments which focus on hand function. These involve grasping and releasing different everyday objects and performing everyday tasks as well as quality of life questionnaires.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New South Wales
      • Randwick, New South Wales, Australia
        • Spinal Unit, Prince of Wales Hospital
      • Sydney, New South Wales, Australia
        • Royal Rehabilitation Centre Sydney
    • Queensland
      • Woolloongabba, Queensland, Australia
        • Queensland Spinal Cord Injury Service, Princess Alexandra Hospital
    • South Australia
      • Northfield, South Australia, Australia
        • South Australian Spinal Cord Injury Service, Hampstead Rehabilitation Centre
    • Victoria
      • Kew, Victoria, Australia, 3101
        • Victorian Spinal Cord Injury Service, Royal Talbot Rehabilitation Centre
    • Western Australia
      • Shenton Park, Western Australia, Australia
        • Sir George Bebrook Spinal Injuries Centre, Royal Perth Hospital
      • Christchurch, New Zealand
        • Burwood Academy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients will be included if they:

  1. have sustained a SCI within the preceding 6 months from time of consent
  2. are currently receiving inpatient rehabilitation through one of the study sites
  3. will remain in hospital for 12 weeks after initial screening as part of their standard medical/rehabilitation care
  4. are 16 years of age or older and able to provide informed consent
  5. have a motor complete or incomplete spinal cord injury at the neurological level of C2 to T1 (as per the International Standardised Neurological Assessment for SCI)
  6. can actively flex their shoulder/s to 60 degrees
  7. have reduced ability to grasp using their hands
  8. are able to tolerate sufficient FES to enable one hand to grasp and release
  9. have the potential to benefit from FES and ReJoyce according to the judgment of the treating therapist

Exclusion Criteria:

Patients will not be included if they:

  1. have any other type of neurological injury affecting the target hand (e.g. brachial plexus or peripheral nerve injuries)
  2. have had recent trauma or surgery to the target hand or upper limb within the last 12 months
  3. have had amputation of any digits on the target hand
  4. are not able to sit out of bed each day for at least 2 hours over three consecutive days
  5. have extensive fixed contractures in the upper limb of the target hand preventing use of the ReJoyce
  6. have severe spasticity in the target hand or upper limb preventing use of the ReJoyce
  7. are unable to attend the 6-month and 1-year follow-up assessments at their treating spinal unit
  8. are likely to undergo hand surgery in the target hand in the next year
  9. might experience autonomic dysreflexia and/or hypotension in response to electrical stimulation
  10. have any contraindications to FES, such as cardiac pacemaker, epilepsy, forearm fracture or pregnancy
  11. have intracranial metal implants
  12. have impaired vision and/or are unable to view a computer screen
  13. have any other serious medical condition including malignancies, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant's ability to cooperate or in the opinion of the study investigator would prevent the participant from adhering to the Protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group

In addition to standard care participants in Group A will receive:

• One hour of extra hand training five times per week for 8 weeks using the ReJoyce Workstation.

The training will be supervised by a therapist and provided to the target hand. The hand exercises will be incorporated into computer games and will involve the following tasks using different manipulanda:

  • reaching
  • grasping
  • manipulating
  • pulling
  • rotating
  • releasing
The device has two parts. A muscle-stimulator garment that incorporates a wireless-triggered stimulator cuff and an earpiece, similar to a hearing aid, that sends a radio signal to the stimulator cuff. As well as a specialised workstation known as ReJoyce, which connects to a standard computer via a USB port. This work station will allow the user to play specialised computer games focusing on hand function. The stimulator system and the ReJoyce workstation were developed by Professor Arthur Prochazka, University of Alberta, Canada and has been approved by the Canadian Standards Association.
All participants will continue to receive the same standard care for the hand and upper limb as typically provided by their rehabilitation units.
Other: Standard Care Group
Participants in the control group will not receive any training on the instrumented workstation or electrical stimulation to the hand or upper limb. They will however continue to receive standard care as well as three 15-minute specific hand activity sessions per week specifically devoted to the practice of hand activities in a one-to-one format with a therapist (as per the treatment received by the experimental group).
All participants will continue to receive the same standard care for the hand and upper limb as typically provided by their rehabilitation units.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Action Research Arm Test
Time Frame: 8 weeks and 26 weeks
A standardized measure of unilateral hand and upper limb function
8 weeks and 26 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Summed Upper Limb Strength of the Graded and Redefined Assessment of Strength Sensibility and Prehension
Time Frame: 8 weeks and 26 weeks
Summed strength score of 10 upper limb muscles
8 weeks and 26 weeks
Sensory Score on ISNCSCI
Time Frame: 8 weeks and 26 weeks
Scores for light touch and pinprick tested in dermatomes of the upper limb
8 weeks and 26 weeks
AsTex Sensory Test
Time Frame: 8 weeks and 26 weeks
A measure of texture discrimination in the fingertips
8 weeks and 26 weeks
AuSpinal Test
Time Frame: 8 weeks and 26 weeks
A test of hand function
8 weeks and 26 weeks
Capabilities of Upper Extremity
Time Frame: 8 weeks and 26 weeks
A questionnaire about upper limb function
8 weeks and 26 weeks
Assessment of Quality of Life (AQoL)
Time Frame: 8 weeks and 26 weeks
A questionnaire to assess quality of life
8 weeks and 26 weeks
Health Utilities Index Mark 3
Time Frame: 8 weeks and 24 weeks
A questionnaire to assess quality of life, but includes a domain on hand function
8 weeks and 24 weeks
Self-care subscale of the Spinal Cord Independence Measure
Time Frame: 8 weeks and 24 weeks
A questionnaire about independence in self-care
8 weeks and 24 weeks
Goal Attainment Scale
Time Frame: 8 weeks
An assessment of whether a participant achieved pre-set goals
8 weeks
Participant Perception of Treatment Effectiveness
Time Frame: 8 weeks
Self resport of treatment effectiveness
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lisa Harvey, University of Sydney
  • Principal Investigator: Mary Galea, University of Melbourne
  • Principal Investigator: Sarah Dunlop, The University of Western Australia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

March 12, 2010

First Submitted That Met QC Criteria

March 12, 2010

First Posted (Estimate)

March 15, 2010

Study Record Updates

Last Update Posted (Actual)

May 3, 2021

Last Update Submitted That Met QC Criteria

April 28, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will only be provided in aggregate. No individual data will be released, as per the ethics approval.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injury

Clinical Trials on ReJoyce Workstation

3
Subscribe